The citations below is a result of Institute
for Scientific Information Science
Citation Index search
Citing Article
THE
SOLUBLE FORM OF ALZHEIMERS AMYLOID-BETA PROTEIN IS COMPLEXED TO HIGH-DENSITY-LIPOPROTEIN-3
AND VERY HIGH-DENSITY-LIPOPROTEIN IN NORMAL HUMAN PLASMA
KOUDINOV A, FRANGIONE B, GHISO J
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
205: (2) 1164-1171 DEC 15 1994
58
papers by July 20, 2001
(please note: selected papers provide
links to the PubMed abstracts)
51-58
Curtain CC, Ali F, Volitakis
I, et al.
Alzheimer's disease amyloid-beta binds copper and
zinc to generate an allosterically ordered membrane-penetrating structure
containing superoxide dismutase-like subunits
J BIOL CHEM 276 (23): 20466-20473 JUN 8 2001
Cedazo-Minguez A, Wiehager
B, Winblad B, et al.
Effects of apolipoprotein E (apoE) isoforms, beta-amyloid
(A beta) and apoE/A beta complexes on protein kinase C-alpha (PKC-alpha)
translocation and amyloid precursor protein (APP) processing in human SH-SY5Y
neuroblastoma cells and fibroblasts
NEUROCHEM INT 38 (7): 615-625 JUN 2001
Cedazo-Minguez A, Huttinger
M, Cowburn RF
beta-VLDL protects against A beta(I-42) and apoE
toxicity in human SH-SY5Y neuroblastoma cells
NEUROREPORT 12 (2): 201-206 FEB 12 2001
Kontush A, Berndt C, Weber W,
et al.
Amyloid-beta is an antioxidant for lipoproteins in cerebrospinal
fluid and plasma
FREE RADICAL BIO MED 30: (1) 119-128 JAN 1 2001
Vanderstichele H, Van Kerschaver
E, Hesse C, et al.
Standardization of measurement of beta-amyloid((1-42))
in cerebrospinal fluid and plasma
AMYLOID 7: (4) 245-258 DEC 2000
Cavani S, Tamaoka A, Moretti
A, et al.
Plasma levels of amyloid beta 40 and 42 are independent
from ApoE genotype and mental retardation in Down syndrome
AM J MED GENET 95: (3) 224-228 NOV 27 2000
Fagan AM, Holtzman DM
Astrocyte lipoproteins, effects of apoE on neuronal
function, and role of apoE in amyloid-beta deposition in vivo
MICROSC RES TECHNIQ 50: (4) 297-304 AUG 15 2000
Calero M, Rostagno A, Matsubara
E, et al.
Apolipoprotein J (clusterin) and Alzheimer's disease
MICROSC RES TECHNIQ 50: (4) 305-315 AUG 15 2000
41-50
Cole GM, Ard MD
Influence of lipoproteins on microglial degradation
of Alzheimer's amyloid beta-protein
MICROSC RES TECHNIQ 50: (4) 316-324 AUG 15 2000
Golabek AA, Kida E, Walus
M, et al.
Sodium dodecyl sulfate-resistant complexes of Alzheimer's
amyloid beta-peptide with the N-terminal, receptor binding domain of apolipoprotein
E
BIOPHYS J 79: (2) 1008-1015 AUG 2000
Fagan AM, Younkin LH, Morris
JC, et al.
Differences in the A beta 40/A beta 42 ratio associated
with cerebrospinal fluid lipoproteins as a function of
apolipoprotein E genotype
ANN NEUROL 48: (2) 201-210 AUG 2000
Tokuda T, Calero M, Matsubara
E, et al.
Lipidation of apolipoprotein E influences its isoform-specific
interaction with Alzheimer's amyloid beta peptides
BIOCHEM J 348: 359-365 Part 2 JUN 1 2000
Merched A, Xia Y, Visvikis
S, et al.
Decreased high-density lipoprotein cholesterol and
serum apolipoprotein AI concentrations are highly correlated with the severity
of Alzheimer's disease
NEUROBIOL AGING 21: (1) 27-30 JAN-FEB 2000
Schippling S, Kontush A, Arlt
S, et al.
Increased lipoprotein oxidation in Alzheimer's disease
FREE RADICAL BIO MED 28: (3) 351-360 FEB 1 2000
Ray I, Chauhan A, Wegiel J, et
al.
Gelsolin
inhibits the fibrillization of amyloid beta-protein, and also defibrillizes
its preformed fibrils
BRAIN RES 853: (2) 344-351 JAN 24 2000
Koudinov AR, Koudinova NV, Berezov
TT, et al.
HDL
phospholipid: a natural inhibitor of Alzheimer's amyloid beta-fibrillogenesis?
CLIN CHEM LAB MED 37: (10) 993-994 OCT 1999
Kalman J, Kudchodkar BJ, Murray
K, et al.
Evaluation
of serum-lipid-related cardiovascular risk factors in Alzheimer's disease
DEMENT GERIATR COGN 10: (6) 488-493 NOV-DEC 1999
Fagan AM, Holtzman DM, Munson
G, et al.
Unique
lipoproteins secreted by primary astrocytes from wild type, apoE (-/-),
and human apoE transgenic mice
J BIOL CHEM 274: (42) 30001-30007 OCT 15 1999
31-40
Li QX, Fuller SJ, Beyreuther
K, et al.
The
amyloid precursor protein of Alzheimer disease in human brain and blood
J LEUKOCYTE BIOL 66: (4) 567-574 OCT 1999
Scharnagl H, Tisljar U, Winkler
K, et al.
The
beta A4 amyloid peptide complexes to and enhances the uptake of beta-very
low density lipoproteins by the low density lipoprotein receptor-related
protein and heparan sulfate proteoglycans pathway
LAB INVEST 79: (10) 1271-1286 OCT 1999
Cole GM, Beech W, Frautschy SA,
et al.
Lipoprotein
effects on A beta accumulation and degradation by microglia in vitro
J NEUROSCI RES 57: (4) 504-520 AUG 15 1999
Koudinova NV, Berezov TT, Koudinov
AR
beta-amyloid:
Alzheimer's disease and brain beta-amyloidoses
BIOCHEMISTRY-MOSCOW+ 64: (7) 752-757 JUL 1999
Mulder M, Terwel D
Possible
link between lipid metabolism and cerebral amyloid angiopathy in Alzheimer's
disease: A role for high-density lipoproteins?
HAEMOSTASIS 28: (3-4) 174-194 MAY-AUG 1998
Bohrmann B, Tjernberg L, Kuner
P, et al.
Endogenous
proteins controlling amyloid beta-peptide polymerization - Possible implications
for beta-amyloid formation in the central nervous system and in peripheral
tissues
J BIOL CHEM 274: (23) 15990-15995 JUN 4 1999
Chauhan VPS, Ray I, Chauhan A,
et al.
Binding
of gelsolin, a secretory protein, to amyloid beta-protein
BIOCHEM BIOPH RES CO 258: (2) 241-246 MAY 10 1999
Matsubara E, Ghiso J, Frangione
B, et al.
Lipoprotein-free
amyloidogenic peptides in plasma are elevated in patients with sporadic
Alzheimer's disease and Down's syndrome
ANN NEUROL 45: (4) 537-541 APR 1999
-
Ray I, Chauhan A, Wisniewski
HM, et al.
-
Binding
of amyloid beta-protein to intracellular brain proteins in rat and human
NEUROCHEM RES 23: (10) 1277-1282 OCT 1998
-
Koudinov AR, Berezov TT, Koudinova
NV
-
Alzheimer's
amyloid beta and lipid metabolism: a missing link?
FASEB J 12: (12) 1097-1099 SEP 1998
21-30
-
Teplow DB
-
Structural
and kinetic features of amyloid beta-protein fibrillogenesis
AMYLOID 5: (2) 121-142 JUN 1998
-
Kudinova NV, Beavis RC, Berezov
TT, et al.
-
Isolation
and characterization of soluble beta-amyloid and apolipoproteins from cerebrospinal
fluid
BIUL EXP BIOL MED+ 124: (10) 995-998 OCT 1997
-
Atwood CS, Moir RD, Huang XD,
et al.
-
Dramatic
aggregation of Alzheimer A beta by Cu(II) is induced by conditions representing
physiological acidosis
J BIOL CHEM 273: (21) 12817-12826 MAY 22 1998
-
Kindy MS, Rader DJ
-
Reduction
in amyloid A amyloid formation in apolipoprotein-E-deficient mice
AM J PATHOL 152: (5) 1387-1395 MAY 1998
-
Koudinova NV, Berezov TT, Koudinov
AR
-
Alzheimer's
disease: Beta amyloid and lipid metabolism.
VOP MED KHIM 44: (1) 28-34 JAN-FEB 1998
-
LaDu MJ, Gilligan SM, Lukens
JR, et al.
-
Nascent
astrocyte particles differ from lipoproteins in CSF
J NEUROCHEM 70: (5) 2070-2081 MAY 1998
-
Koudinov AR, Berezov TT, Kumar
A, et al.
-
Alzheimer's
amyloid beta interaction with normal human plasma high density lipoprotein:
association with apolipoprotein and lipids
CLIN CHIM ACTA 270: (2) 75-84 FEB 23 1998
-
Wisniewski T, Ghiso J, Frangione
B
-
Biology
of A beta amyloid in Alzheimer's disease
NEUROBIOL DIS 4: (5) 313-328 1997
Verbeek MM, Ruiter DJ, deWaal
RMW
-
The
role of amyloid in the pathogenesis of Alzheimer's disease
BIOL CHEM 378: (9) 937-950 SEP 1997
-
Koudinov AR, Koudinova NV
-
Alzheimer's
soluble amyloid beta protein is secreted by HepG2 cells as an apolipoprotein
CELL BIOL INT 21: (5) 265-271 MAY 1997
11-20
-
LaDu MJ, Lukens JR, Reardon CA,
et al.
-
Association
of human, rat, and rabbit apolipoprotein E with beta-amyloid
J NEUROSCI RES 49: (1) 9-18 JUL 1 1997
-
Farhangrazi ZS, Ying H, Bu GJ,
et al.
-
High
density lipoprotein decreases beta-amyloid toxicity in cortical cell culture
NEUROREPORT 8: (5) 1127-1130 MAR 24 1997
-
Ghiso J, Calero M, Matsubara
E, et al.
-
Alzheimer's
soluble amyloid beta is a normal component of human urine
FEBS LETT 408: (1) 105-108 MAY 12 1997
-
Martel CL, Ghiso J, Frangione
B, et al.
-
Transport of apolipoproteins E and J at the blood-brain barrier - Relevance
to Alzheimer's disease
STP PHARMA SCI 7: (1) 28-36 JAN-FEB 1997
-
Puttfarcken PS, Manelli AM, Falduto
MT, et al.
-
Effect
of apolipoprotein E on neurite outgrowth and beta-amyloid-induced toxicity
in developing rat primary hippocampal cultures
J NEUROCHEM 68: (2) 760-769 FEB 1997
-
Shayo M, McLay RN, Kastin AJ,
et al.
-
The
putative blood-brain barrier transporter for the beta-amyloid binding protein
apolipoprotein J is saturated at physiological concentrations
LIFE SCI 60: (7) PL115-PL118 JAN 10 1997
-
Biere AL, Ostaszewski B, Stimson
ER, et al.
-
Amyloid
beta-peptide is transported on lipoproteins and albumin in human plasma
J BIOL CHEM 271: (51) 32916-32922 DEC 20 1996
-
Koudinova NV, Berezov TT, Koudinov
AR
-
Multiple
inhibitory effects of Alzheimer's peptide A beta 1-40 on lipid biosynthesis
in cultured human HepG2 cells
FEBS LETT 395: (2-3) 204-206 OCT 21 1996
-
Zlokovic BV
-
Cerebrovascular
transport of Alzheimer's amyloid beta and apolipoproteins J and E: Possible
anti-amyloidogenic role of the blood-brain barrier
LIFE SCI 59: (18) 1483-1497 SEP 27 1996
-
Koudinov AR, Koudinova NV, Berezov
TT
-
Alzheimer's
peptides A beta 1-40 and A beta 1-28 inhibit the plasma cholesterol esterification
rate.
BIOCHEM MOL BIOL INT 38: (4) 747-752 APR 1996
1-10
-
GhersiEgea JF, Gorevic PD, Ghiso
J, et al.
-
Fate
of cerebrospinal fluid-borne amyloid beta-peptide: Rapid clearance into
blood and appreciable accumulation by cerebral arteries
J NEUROCHEM 67: (2) 880-883 AUG 1996
-
Matsubara E, Soto C, Governale
S, et al.
-
Apolipoprotein
J and Alzheimer's amyloid beta solubility
BIOCHEM J 316: 671-679 Part 2 JUN 1 1996
-
Koudinov AR, Koudinova NV, Kumar
A, et al.
-
Biochemical
characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal
fluid: Association with high density lipoproteins
BIOCHEM BIOPH RES CO 223: (3) 592-597 JUN 25 1996
-
Zlokovic BV, Martel CL, Matsubara
E, et al.
-
Glycoprotein
330/megalin: Probable role in receptor-mediated transport of apolipoprotein
J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain
and blood-cerebrospinal fluid barriers
P NATL ACAD SCI USA 93: (9) 4229-4234 APR 30 1996
-
Harr SD, Uint L, Hollister R,
et al.
-
Brain
expression of apolipoproteins E, J, and A-I in Alzheimer's disease
J NEUROCHEM 66: (6) 2429-2435 JUN 1996
-
Shuvaev VV, Siest GR
-
Interaction
between human amphipathic apolipoproteins and amyloid beta-peptide: Surface
plasmon resonance studies
FEBS LETT 383: (1-2) 9-12 MAR 25 1996
-
MAZURKOLECKA B, FRACKOWIAK J,
WISNIEWSKI HM
-
APOLIPOPROTEINS
E3 AND E4 INDUCE, AND TRANSTHYRETIN PREVENTS ACCUMULATION OF THE ALZHEIMERS
BETA-AMYLOID PEPTIDE IN CULTURED VASCULAR SMOOTH-MUSCLE CELLS
BRAIN RES 698: (1-2) 217-222 NOV 6 1995
-
ZLOKOVIC BV
-
CEREBROVASCULAR
PERMEABILITY TO PEPTIDES - MANIPULATIONS OF TRANSPORT-SYSTEMS AT THE BLOOD-BRAIN-BARRIER
PHARMACEUT RES 12: (10) 1395-1406 OCT 1995
-
WISNIEWSKI T, GOLABEK AA, KIDA
E, et al.
-
CONFORMATIONAL
MIMICRY IN ALZHEIMERS-DISEASE - ROLE OF APOLIPOPROTEINS IN AMYLOIDOGENESIS
AM J PATHOL 147: (2) 238-244 AUG 1995
-
MATSUBARA E, FRANGIONE B, GHISO
J
-
CHARACTERIZATION
OF APOLIPOPROTEIN J-ALZHEIMERS A-BETA INTERACTION
J BIOL CHEM 270: (13) 7563-7567 MAR 31 1995
Thanks for visiting Drs. Koudinov
Internet Office
Site Design and Programming © Alexei Koudinov, 2001.
Last updated: July 20, 2001